CN Stock MarketDetailed Quotes

688192 Dizal Pharmaceutical

Watchlist

42.81
-1.44-3.25%

Market Closed Dec 19 15:00 CST

17.79BMarket Cap-21.26P/E (TTM)

Dizal Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dizal Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	134.90M	--
		+236.39%
EPS	--	-0.51	--
		--

Analyst Rating

Strong Buy

Dec 19, 2024

Dizal Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 947.310M	--
--	2024/FY	-- / 455.652M	--
--	2023/FY	91.289M / 108.000M	--
Mar 24, 2023	2022/FY	0.000 / 0.000	--
Feb 26, 2022	2021/FY	10.285M / 11.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 947.310M--

--2024/FY-- / 455.652M--

--2023/FY91.289M / 108.000M--

Mar 24, 20232022/FY0.000 / 0.000--

Feb 26, 20222021/FY10.285M / 11.000M--

Unlock Free Earnings Estimates

Open Account

Dizal Pharmaceutical Earnings Reports

Digel Pharmaceuticals: Digel Pharmaceuticals: Report for the Third Quarter of 2024

Oct 30 12:00 ET

Digel Pharmaceuticals: Third Quarter Report 2024

Oct 30 12:00 ET

Digel Pharmaceuticals: 2024 Semi-Annual Report

Aug 29 12:00 ET

Digel Pharmaceuticals: 2024 Semi-Annual Report Summary

Aug 29 12:00 ET

Symbol Price % Chg

Dark Horse Technology Group

Shanghai Kaytune Industrial

301001

34.19 +20.01%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 19, 2024

Strong Buy

Strong Buy
80.00%
Buy
20.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data